Jeffrey Yu Purchases 142,857 Shares of OneMedNet (NASDAQ:ONMD) Stock

OneMedNet Corporation (NASDAQ:ONMDGet Free Report) insider Jeffrey Yu acquired 142,857 shares of the company’s stock in a transaction that occurred on Thursday, September 10th. The shares were acquired at an average cost of $0.63 per share, with a total value of $89,999.91. Following the purchase, the insider owned 8,923,267 shares in the company, valued at $5,621,658.21. This represents a 1.63% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Jeffrey Yu also recently made the following trade(s):

  • On Tuesday, June 23rd, Jeffrey Yu acquired 158,730 shares of OneMedNet stock. The stock was bought at an average price of $0.63 per share, with a total value of $99,999.90.
  • On Tuesday, June 16th, Jeffrey Yu acquired 172,414 shares of OneMedNet stock. The shares were acquired at an average cost of $0.58 per share, with a total value of $100,000.12.

OneMedNet Stock Performance

Shares of ONMD stock traded up $0.02 during mid-day trading on Monday, hitting $0.67. 244,221 shares of the stock were exchanged, compared to its average volume of 270,916. The stock’s fifty day simple moving average is $0.66 and its two-hundred day simple moving average is $0.75. OneMedNet Corporation has a 12-month low of $0.49 and a 12-month high of $4.22.

OneMedNet (NASDAQ:ONMDGet Free Report) last issued its earnings results on Friday, August 14th. The company reported ($0.04) earnings per share (EPS) for the quarter. The firm had revenue of $0.29 million during the quarter.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Wall Street Zen downgraded shares of OneMedNet from a “hold” rating to a “sell” rating in a research note on Saturday, May 23rd. Weiss Ratings raised OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 24th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of “Sell”.

View Our Latest Stock Analysis on OneMedNet

OneMedNet Company Profile

(Get Free Report)

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.

Further Reading

Insider Buying and Selling by Quarter for OneMedNet (NASDAQ:ONMD)

Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.